Skip to main content

Table 2 Distribution of comorbidities over grades and groups

From: Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study

 

GOLD grades

p value

GOLD groups

p value

total (n = 2255)

GOLD 1 (n = 203)

GOLD 2 (n = 948)

GOLD 3 (n = 863)

GOLD 4 (n = 241)

GOLD A (n = 871)

GOLD B (n = 567)

GOLD C (n = 294)

GOLD D (n = 523)

Asthma (ext.) (%)

39 (19.2)

186 (19.6)

169 (19.6)

32 (13.3)

0.135

137 (15.7)

92 (16.2)

78 (26.5)

119 (22.8)

< 0.001*

426/1829

Sleep Apnea (%)

26 (12.8)

102 (10.8)

93 (10.8)

17 (7.1)

0.230

66 (7.6)

66 (11.6)

29 (9.9)

77 (14.7)

< 0.001*

238/2017

Diabetes (ext) (%)

22 (10.8)

130 (13.7)

114 (13.2)

28 (11.6)

0.637

95 (10.9)

76 (13.4)

31 (10.5)

92 (17.6)

0.002*

294/1961

Hyperlipidemia (ext) (%)

104 (51.2)

432 (45.6)

360 (41.7)

72 (29.9)

< 0.001*

381 (43.7)

224 (39.5)

126 (42.9)

237 (45.3)

0.244

968/1287

Hyperuricemia (ext) (%)

31 (15.3)

183 (19.3)

159 (18.4)

33 (13.7)

0.154

123 (14.1)

114 (20.1)

64 (21.8)

105 (20.1)

0.002*

406/1849

Gastrointestinal disorders (ext) (%)

111 (54.7)

431 (45.5)

388 (45.0)

110 (45.6)

0.084

339 (38.9)

257 (45.3)

140 (47.6)

304 (58.1)

< 0.001*

1040/1215

Hypertension (ext) (%)

103 (50.7)

534 (56.3)

516 (59.8)

126 (52.3)

0.041

461 (52.9)

336 (59.3)

165 (56.1)

317 (60.6)

0.020*

1279/976

Coronary Heart Disease (ext) (%)

36 (17.7)

163 (17.2)

146 (16.9)

43 (17.8)

0.984

114 (13.1)

117 (20.6)

39 (13.3)

118 (22.6)

< 0.001*

388/1867

Myocardial Infarction (%)

13 (6.4)

81 (8.5)

82 (9.5)

13 (5.4)

0.153

65 (7.5)

58 (10.2)

19 (6.5)

47 (9.0)

0.162

189/2066

Heart failure (%)

8 (3.9)

45 (4.8)

50 (5.8)

13 (5.4)

0.633

24 (2.8)

31 (5.5)

16 (5.4)

45 (8.6)

< 0.001*

116/2139

Osteoporosis (ext) (%)

29 (14.3)

127 (13.4)

152 (17.6)

56 (23.2)

0.001*

101 (11.6)

94 (16.6)

43 (14.6)

126 (24.1)

< 0.001*

364/1891

Arthritis (%)

21 (10.3)

78 (8.2)

74 (8.6)

12 (5.0)

0.193

67 (7.7)

52 (9.2)

27 (9.2)

39 (7.5)

0.622

185/2070

Mental disorders (anamnestic report) (%)

43 (21.2)

197 (20.8)

166 (19.2)

57 (23.7)

0.491

140 (16.1)

122 (21.5)

60 (20.4)

141 (27.0)

< 0.001*

463/1792

  1. The table shows the distribution of the different comorbidities according to GOLD grades 1–4 and GOLD groups A-D. The comparisons were performed by the chi-squared statistics, significant differences are marked with * p < 0.05
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us